Vivo-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
40
Total Value
755066478
Accession Number
0001213900-25-041737
Form Type
13F-HR
Manager Name
Vivo-Capital
Data Enrichment
98% identified
39 identified1 unidentified

Holdings

40 positions • $755.1M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Astria Therapeutics, Inc.
Shares:1.6M
Value:$8.3M
% of Portfolio:1.1% ($8.3M/$755.1M)
Akero Therapeutics, Inc.
Shares:201.2K
Value:$8.1M
% of Portfolio:1.1% ($8.1M/$755.1M)
Corvus Pharmaceuticals, Inc.
Shares:2.2M
Value:$7.1M
% of Portfolio:0.9% ($7.1M/$755.1M)
Compass Therapeutics, Inc.
Shares:3.6M
Value:$6.8M
% of Portfolio:0.9% ($6.8M/$755.1M)
IO Biotech, Inc.
Shares:6.2M
Value:$6.7M
% of Portfolio:0.9% ($6.7M/$755.1M)
Cogent Biosciences, Inc.
Shares:1.1M
Value:$6.7M
% of Portfolio:0.9% ($6.7M/$755.1M)
Unicycive Therapeutics, Inc.
Shares:11.4M
Value:$6.5M
% of Portfolio:0.9% ($6.5M/$755.1M)
Celcuity Inc.
Shares:610.5K
Value:$6.2M
% of Portfolio:0.8% ($6.2M/$755.1M)
Rezolute, Inc.
Shares:2.1M
Value:$6.1M
% of Portfolio:0.8% ($6.1M/$755.1M)
SERA PROGNOSTICS, INC.
Shares:1.7M
Value:$6.1M
% of Portfolio:0.8% ($6.1M/$755.1M)
Olema Pharmaceuticals, Inc.
Shares:1.5M
Value:$5.7M
% of Portfolio:0.7% ($5.7M/$755.1M)
Regulus Therapeutics Inc.
Shares:2.7M
Value:$4.7M
% of Portfolio:0.6% ($4.7M/$755.1M)
Silence Therapeutics plc
Shares:1.1M
Value:$3.1M
% of Portfolio:0.4% ($3.1M/$755.1M)
Surrozen, Inc./DE
Shares:260.0K
Value:$3.0M
% of Portfolio:0.4% ($3.0M/$755.1M)
89bio, Inc.
Shares:376.8K
Value:$2.7M
% of Portfolio:0.4% ($2.7M/$755.1M)
Bolt Biotherapeutics, Inc.
Shares:3.5M
Value:$1.4M
% of Portfolio:0.2% ($1.4M/$755.1M)
TENAX THERAPEUTICS, INC.
Shares:208.3K
Value:$1.4M
% of Portfolio:0.2% ($1.4M/$755.1M)
Allakos Inc.
Shares:765.5K
Value:$174.2K
% of Portfolio:0.0% ($174.2K/$755.1M)
Aligos Therapeutics, Inc.
Shares:10.2K
Value:$84.1K
% of Portfolio:0.0% ($84.1K/$755.1M)
PRECISION BIOSCIENCES INC
Shares:4.7K
Value:$22.3K
% of Portfolio:0.0% ($22.3K/$755.1M)